Jim Simons Mi Nk Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 106,687 shares of INKT stock, worth $56,544. This represents 0.0% of its overall portfolio holdings.
Number of Shares
106,687
Previous 127,841
16.55%
Holding current value
$56,544
Previous $121,000
33.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INKT
# of Institutions
29Shares Held
848KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$124,1160.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$88,3320.01% of portfolio
-
Geode Capital Management, LLC Boston, MA98KShares$51,9290.0% of portfolio
-
Black Rock Inc. New York, NY87.2KShares$46,2130.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL51.7KShares$27,4150.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $17.9M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...